Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective Analysis

MLA

Loïc Chaigneau, et al. “Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective Analysis.” Oncology, vol. 100, Jan. 2022, pp. 633–44. EBSCOhost, https://doi.org/10.1159/000527602.

APA

Loïc Chaigneau, Marine Jary, Virginie Nerich, Alice Hervieu, Sébastien Aubry, Céline Charon Barra, Guillaume Meynard, Florent Neumann, Elsa Kalbacher, & Nicolas Isambert. (2022). Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective Analysis. Oncology, 100, 633–644. https://doi.org/10.1159/000527602

Chicago

Loïc Chaigneau, Marine Jary, Virginie Nerich, Alice Hervieu, Sébastien Aubry, Céline Charon Barra, Guillaume Meynard, Florent Neumann, Elsa Kalbacher, and Nicolas Isambert. 2022. “Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective Analysis.” Oncology 100 (January): 633–44. doi:10.1159/000527602.